Filter News
Area of Research
- (-) Biology and Environment (43)
- (-) Neutron Science (8)
- (-) Quantum information Science (1)
- Biological Systems (1)
- Clean Energy (28)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (2)
- Isotopes (5)
- Materials (7)
- Materials for Computing (1)
- National Security (10)
- Nuclear Science and Technology (1)
- Supercomputing (34)
News Type
News Topics
- (-) Big Data (7)
- (-) Bioenergy (29)
- (-) Biomedical (13)
- (-) Space Exploration (1)
- (-) Summit (8)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (8)
- Biology (43)
- Biotechnology (6)
- Chemical Sciences (4)
- Clean Water (10)
- Climate Change (24)
- Composites (1)
- Computer Science (18)
- Coronavirus (7)
- Decarbonization (16)
- Energy Storage (4)
- Environment (61)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (3)
- High-Performance Computing (13)
- Hydropower (5)
- Machine Learning (7)
- Materials (6)
- Materials Science (9)
- Mathematics (3)
- Mercury (6)
- Microscopy (10)
- Nanotechnology (5)
- National Security (3)
- Net Zero (1)
- Neutron Science (34)
- Nuclear Energy (1)
- Physics (2)
- Polymers (2)
- Quantum Computing (1)
- Quantum Science (5)
- Renewable Energy (1)
- Security (2)
- Simulation (9)
- Sustainable Energy (18)
- Transportation (2)
Media Contacts
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Cory Stuart of ORNL applies his expertise as a systems engineer to ensure the secure and timely transfer of millions of measurements of Earth’s atmosphere, fueling science around the world.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Popular wisdom holds tall, fast-growing trees are best for biomass, but new research by two U.S. Department of Energy national laboratories reveals that is only part of the equation.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
Biological membranes, such as the “walls” of most types of living cells, primarily consist of a double layer of lipids, or “lipid bilayer,” that forms the structure, and a variety of embedded and attached proteins with highly specialized functions, including proteins that rapidly and selectively transport ions and molecules in and out of the cell.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have developed a new method to peer deep into the nanostructure of biomaterials without damaging the sample. This novel technique can confirm structural features in starch, a carbohydrate important in biofuel production.